Ibrutinib With Rituximab in Mantle Cell Lymphoma Ibrutinib With Rituximab in Mantle Cell Lymphoma

Combination therapy with ibrutinib and rituximab appears to be effective among elderly patients with mantle cell lymphoma, but cardiac toxicity remains a concern.Journal of Clinical Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news